Orange Book product · Generic (ANDA)
STAVUDINE
STAVUDINE
At a glance
Dec 29, 2008
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 29, 2008
17 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
STAVUDINE
Strength
15MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 078957
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of STAVUDINE
- 2002ZERIT XRBrand (NDA)
NDA 021453 · BRISTOL MYERS SQUIBB
- 1996ZERITBrand (NDA)
NDA 020413 · BRISTOL
- 1994ZERITBrand (NDA)
NDA 020412 · BRISTOL
- 2009STAVUDINEGeneric (ANDA)
ANDA 078030 · CIPLA LTD
- 2009STAVUDINEGeneric (ANDA)
ANDA 078775 · PHARMOBEDIENT
- 2008STAVUDINEGeneric (ANDA)
ANDA 077672 · AUROBINDO PHARMA
- 2008STAVUDINEGeneric (ANDA)
ANDA 079069 · PHARMOBEDIENT
- 2008STAVUDINEGeneric (ANDA)
ANDA 077774 · AUROBINDO PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
